Search results
Tired of sports betting ad bombardment? So is a big sportsbook exec: Caesar's Better Bettor
St. Louis Post-Dispatch· 5 days agoAre you weary of begin inundated with advertisements for sports betting operators when watching a...
Muny concerts are back: John Legend to perform with SLSO
St. Louis Post-Dispatch· 7 days agoThe Muny is calling on a legend to revise an old tradition. Grammy-, Tony-, Emmy- and Academy...
Battlehawks clinch playoff berth as QB Manny Wilkins makes first start in 6 years
St. Louis Post-Dispatch· 3 days agoWhile biding his time awaiting another shot at football, Manny Wilkins worked out, worked on his...
Nashville hot chicken chain to open 7 locations in St. Louis area
St. Louis Post-Dispatch· 7 days agoLouis. With brand investors like rapper Drake, actor Samuel L. Jackson and retired NFL player...
Survival of Missouri constitutional amendment plan in doubt after Democrats block vote
St. Louis Post-Dispatch· 5 days agoAn effort aimed at restricting citizen-led initiative petitions was on life support Thursday amid...
Buck-Caray combo returns to Cardinals broadcast booth next week: Media Views
St. Louis Post-Dispatch· 6 days agoCaray and Buck will be broadcasting the Cardinals, just like in the team’s glory decade of the...
Former NHL Player Aaron Ward Details the Depths of His Gambling Addiction
Covers.com· 2 days agoWard joins a growing list of professional athletes who’ve recently admitted to or been otherwise...
Matthew Brown: No. 1 works of art on display
The Union-Recorder, Milledgeville, Ga. via Yahoo Sports· 4 days agoMay 17—Sometimes, you have to step back and concede the spotlight to others, like state champions, conference champions and Players of the Year. That's what's taken up the bulk of weekend sports ...
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
Morningstar· 6 days agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) and Biogen Inc. (Nasdaq: BIIB) announced the decision to terminate development of BIIB105 (ION541) an investigational antisense oligonucleotide (ASO ...
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
Morningstar· 6 days agoBiogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the decision to terminate development of BIIB105 (ION541) an investigational antisense oligonucleotide (ASO ...